Form 8-K - Current report:
SEC Accession No. 0001193125-21-264494
Filing Date
2021-09-02
Accepted
2021-09-02 16:06:07
Documents
13
Period of Report
2021-08-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d203866d8k.htm   iXBRL 8-K 25371
  Complete submission text file 0001193125-21-264494.txt   190384

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210827.xsd EX-101.SCH 3963
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210827_def.xml EX-101.DEF 14267
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210827_lab.xml EX-101.LAB 23647
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210827_pre.xml EX-101.PRE 15300
6 EXTRACTED XBRL INSTANCE DOCUMENT d203866d8k_htm.xml XML 6660
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 211233281
SIC: 2834 Pharmaceutical Preparations